Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building new antifungals has actually gotten a substantial increase fr...

Capricor sells Europe civil rights to late-stage DMD treatment for $35M

.Having actually gathered up the united state rights to Capricor Therapies' late-stage Duchenne musc...

FDA junks adcomm for Applied's rare disease medicine

.After pushing the decision meeting for Applied Rehabs' metabolic condition drug govorestat, the FDA...

Novo inks $600M NanoVation bargain to research genetic drugs ex-liver

.Novo Nordisk is proceeding its push right into hereditary medicines, agreeing to pay NanoVation The...

Innovent links cytokine to intestines cancer cells reactions

.Innovent Biologics has created the case that its gate inhibitor-cytokine combination healthy protei...

Merck, Daiichi ADC strikes goal in period 3 bronchi cancer cells study

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina grows AI focus along with collab to pick cancer cells targets

.5 months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech has j...

Ascendis' dwarfism medication smash hits in phase 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a prospective hazard to BioMarin's Voxzogo, mentioning phas...

Despite ph. 3 skip, Alkeus sees path in advance for eye disease property

.Though Alkeus Pharmaceuticals' oral eye illness resource neglected to substantially lower geographi...

Kairos goes social with $6M IPO to fund tests of cancer medication

.With a trio of biotechs attacking the Nasdaq on Friday, it was easy to miss out on a smaller-scale ...